Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

26th EORTC-NCI-AACR Symposium

18 - 21 Nov 2014
Centre de Convencions Internacional Barcelona (CCIB), Barcelona, Spain
Videos
News

Highlights of the EORTC-NCI-AACR Symposium

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Highlights of the EORTC-NCI-AACR Symposium ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Dec 2014

Predicting the relapse of acute myeloid leukaemia with genetic screening

Dr Elaine Mardis - University of Washington, Washington, USA
Predicting the relapse of acute myeloid leukaemia with genetic screening ( Dr Elaine Mardis - University of Washington, Washington, USA )
2 Dec 2014

Choosing personalised treatment options based on molecular evidence

Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA
Choosing personalised treatment options based on molecular evidence ( Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA )
1 Dec 2014

Frontiers of pharmacokinetics and metabolism in cancer research

Prof Godefridus Peters - VU University Medical Center, Amsterdam, Netherlands
Frontiers of pharmacokinetics and metabolism in cancer research ( Prof Godefridus Peters - VU University Medical Center, Amsterdam, Netherlands )
1 Dec 2014

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

Overcoming cancer resistance with enzyme inhibitors

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Overcoming cancer resistance with enzyme inhibitors ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
27 Nov 2014

New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer

Dr Haruyasu Murakami - Shizuoka Cancer Center, Shizuoka, Japan
New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer ( Dr Haruyasu Murakami - Shizuoka Cancer Center, Shizuoka, Japan )
27 Nov 2014

The work and aims of SPECTA for better clinical trials

Dr Vassilis Golfinopoulos - European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium
The work and aims of SPECTA for better clinical trials ( Dr Vassilis Golfinopoulos - European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium )
27 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation